Relapse Risk and Survival in Patients with FLT3 Acute Myeloid Leukemia Undergoing Stem Cell Transplantation

In patients with AML with FMS-like tyrosine kinase 3 (FLT3) mutations, the significance of minimal residual disease (MRD) detected by PCR before allogeneic stem cell transplantation (SCT) on outcomes after transplant remains unclear. We identified 200 patients with FLT3-AML who underwent SCT at our...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Am J Hematol
मुख्य लेखकों: Gaballa, Sameh, Saliba, Rima, Oran, Betul, Brammer, Jonathan E., Chen, Julianne, Rondon, Gabriela, Alousi, Amin M., Kebriaei, Partow, Marin, David, Popat, Uday R., Andersson, Borje S., Shpall, Elizabeth J., Jabbour, Elias, Daver, Naval, Andreeff, Michael, Ravandi, Farhad, Cortes, Jorge, Patel, Keyur, Champlin, Richard E., Ciurea, Stefan O.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2017
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352512/
https://ncbi.nlm.nih.gov/pubmed/28052408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24632
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन